Morning trading October 23, page-6

AVE

I expect 1c to get cleared and the 52 week highs of 1.2c to be tested very quickly.

Almost an identical setup to PAB, major breakout above 52 week highs.

Biotech stock. $14M cap with $4.5M cash. One of the best performing TPM formulations out there. CBD sales were $4.7Bn last year.

First human clinical dosing to begin in Q1 2021. Sub $10M EV leading into clinical trials is just unheard of. Most stocks are $30-50M leading into human clinical trials. AVE starts their first dosing in Q1.

Watch this one move very quickly. I like that the herd isn't all over it either, hardly a peep on it yet.